scholarly article | Q13442814 |
P50 | author | Paul A Trainor | Q48687276 |
P2093 | author name string | Paul A Trainor | |
Han Liu | |||
Emily H Cheng | |||
James J Hsieh | |||
Shugaku Takeda | |||
Yiyu Dong | |||
Satoru Sasagawa | |||
P2860 | cites work | Taspase1: a threonine aspartase required for cleavage of MLL and proper HOX gene expression | Q24300473 |
Stimulation of 92-kDa gelatinase B promoter activity by ras is mitogen-activated protein kinase kinase 1-independent and requires multiple transcription factor binding sites including closely spaced PEA3/ets and AP-1 sequences. | Q38358011 | ||
Phosphorylation of MLL by ATR is required for execution of mammalian S-phase checkpoint | Q39659313 | ||
Unique and independent roles for MLL in adult hematopoietic stem cells and progenitors | Q39997748 | ||
Hepatocyte growth factor signalling stimulates hypoxia inducible factor-1 (HIF-1) activity in HepG2 hepatoma cells | Q40782785 | ||
Hepatocyte growth factor upregulates E1AF that induces oral squamous cell carcinoma cell invasion by activating matrix metalloproteinase genes | Q40876225 | ||
Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells | Q40993570 | ||
The c-Ets oncoprotein activates the stromelysin promoter through the same elements as several non-nuclear oncoproteins | Q41080680 | ||
Bimodal degradation of MLL by SCFSkp2 and APCCdc20 assures cell cycle execution: a critical regulatory circuit lost in leukemogenic MLL fusions | Q41436188 | ||
Human corneal epithelial cells require MMP-1 for HGF-mediated migration on collagen I. | Q42437431 | ||
Mechanisms of hepatocyte growth factor stimulation of keratinocyte metalloproteinase production | Q42522963 | ||
Scatter factor is a fibroblast-derived modulator of epithelial cell mobility | Q42807925 | ||
The Ets-1 and Ets-2 transcription factors activate the promoters for invasion-associated urokinase and collagenase genes in response to epidermal growth factor | Q47929963 | ||
Ets-1 transcription factor-mediated urokinase-type plasminogen activator expression and invasion in glioma cells stimulated by serum and basic fibroblast growth factors | Q48231412 | ||
Hoxa3 Regulates Integration of Glossopharyngeal Nerve Precursor Cells | Q52125398 | ||
The branchial arches and HGF are growth-promoting and chemoattractant for cranial motor axons | Q52169915 | ||
Regulation of Pax-3 expression in the dermomyotome and its role in muscle development | Q52217598 | ||
E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases. | Q52681173 | ||
Inhibition of vascular endothelial growth factor-induced endothelial cell migration by ETS1 antisense oligonucleotides | Q73352924 | ||
Invasiveness of hepatocellular carcinoma cell lines: contribution of hepatocyte growth factor, c-met, and transcription factor Ets-1 | Q74438273 | ||
Licensed to elongate: a molecular mechanism for MLL-based leukaemogenesis | Q85036285 | ||
Molecular cloning and expression of human hepatocyte growth factor | Q24305558 | ||
Uncleaved TFIIA is a substrate for taspase 1 and active in transcription | Q24548040 | ||
Cell signaling by receptor tyrosine kinases | Q24598357 | ||
Met, metastasis, motility and more | Q28235183 | ||
Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase | Q28286701 | ||
Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud | Q28506228 | ||
Mice homozygous for a targeted disruption of Hoxd-3 (Hox-4.1) exhibit anterior transformations of the first and second cervical vertebrae, the atlas and the axis | Q28588504 | ||
Specification of axial identity in the mouse: role of the Hoxa-5 (Hox1.3) gene | Q28590721 | ||
Targeted disruption of the Hoxb-2 locus in mice interferes with expression of Hoxb-1 and Hoxb-4 | Q28592544 | ||
Hox Group 3 Paralogous Genes Act Synergistically in the Formation of Somitic and Neural Crest-Derived Structures | Q28593097 | ||
MLL targets SET domain methyltransferase activity to Hox gene promoters | Q28609771 | ||
MLL translocations, histone modifications and leukaemia stem-cell development | Q29615368 | ||
Hox genes in vertebrate development | Q29618109 | ||
Matrix metalloproteinases: regulators of the tumor microenvironment | Q29619858 | ||
Altered Hox expression and segmental identity in Mll-mutant mice | Q29620391 | ||
Of extracellular matrix, scaffolds, and signaling: tissue architecture regulates development, homeostasis, and cancer. | Q30355361 | ||
Semi-automated quantification of axonal densities in labeled CNS tissue | Q33233560 | ||
Hepatocyte growth factor, a versatile signal for developing neurons | Q33589398 | ||
Regulation of matrix metalloproteinase expression in tumor invasion. | Q33605726 | ||
Mouse models in the study of the Ets family of transcription factors | Q34139383 | ||
Molecular genetics of cranial nerve development in mouse | Q34354367 | ||
Proteolysis of MLL family proteins is essential for taspase1-orchestrated cell cycle progression. | Q34563234 | ||
Mutant alleles of the Drosophila trithorax gene produce common and unusual homeotic and other developmental phenotypes. | Q34606947 | ||
Proteolytically cleaved MLL subunits are susceptible to distinct degradation pathways | Q35041289 | ||
How to make tubes: signaling by the Met receptor tyrosine kinase | Q35147372 | ||
Homeotic transformation of cervical vertebrae in Hoxa-4 mutant mice | Q35996071 | ||
Targeting the HGF/Met signalling pathway in cancer. | Q36142604 | ||
Species selectivity of mixed-lineage leukemia/trithorax and HCF proteolytic maturation pathways | Q36315316 | ||
Mammalian Trithorax and polycomb-group homologues are antagonistic regulators of homeotic development | Q36745250 | ||
Biphasic MLL takes helm at cell cycle control: implications in human mixed lineage leukemia | Q37072282 | ||
Therapeutic targeting of MLL. | Q37234595 | ||
Pten in stromal fibroblasts suppresses mammary epithelial tumours | Q37399478 | ||
Two independent activation domains in c-Ets-1 and c-Ets-2 located in non-conserved sequences of the ets gene family | Q38330702 | ||
The collagenase gene promoter contains a TPA and oncogene-responsive unit encompassing the PEA3 and AP-1 binding sites | Q38340236 | ||
Induction of multiple matrix metalloproteinase genes in human hepatocellular carcinoma by hepatocyte growth factor via a transcription factor Ets-1. | Q38347090 | ||
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 3154-3165 | |
P577 | publication date | 2013-06-24 | |
P1433 | published in | Journal of Clinical Investigation | Q3186904 |
P1476 | title | HGF-MET signals via the MLL-ETS2 complex in hepatocellular carcinoma | |
P478 | volume | 123 |
Q35122366 | Challenges and opportunities in targeting the menin-MLL interaction |
Q40315218 | Correlations of microvascular blood flow of contrast-enhanced ultrasound and HGF/c-Met signaling pathway with clinicopathological features and prognosis of patients with hepatocellular carcinoma |
Q90884788 | ETS2 promotes epithelial-to-mesenchymal transition in renal fibrosis by targeting JUNB transcription |
Q37099769 | Effectiveness of AMD3100 in treatment of leukemia and solid tumors: from original discovery to use in current clinical practice |
Q92001987 | Epigenetic regulation of histone H3 in the process of hepatocellular tumorigenesis |
Q38806819 | Gene of the month: HGF. |
Q92519795 | HSP90 Molecular Chaperones, Metabolic Rewiring, and Epigenetics: Impact on Tumor Progression and Perspective for Anticancer Therapy |
Q33890276 | Hepatocyte growth factor regulates the TGF-β1-induced proliferation, differentiation and secretory function of cardiac fibroblasts |
Q27006839 | Hijacked in cancer: the KMT2 (MLL) family of methyltransferases |
Q26830271 | Leukemogenic rearrangements at the mixed lineage leukemia gene (MLL)-multiple rather than a single mechanism |
Q36967008 | Linking MLL and the HGF-MET signaling pathway in liver cancer |
Q37255927 | Menin promotes hepatocellular carcinogenesis and epigenetically up-regulates Yap1 transcription |
Q48802654 | Microenvironment of liver regeneration in liver cancer |
Q39181838 | Peritumoral stromal neutrophils are essential for c-Met-elicited metastasis in human hepatocellular carcinoma. |
Q40914650 | Population pharmacokinetics modeling and analysis of foretinib in adult patients with advanced solid tumors |
Q24294703 | Proteasome inhibitors evoke latent tumor suppression programs in pro-B MLL leukemias through MLL-AF4 |
Q28383116 | RNAi screening with shRNAs against histone methylation-related genes reveals determinants of sorafenib sensitivity in hepatocellular carcinoma cells |
Q38746401 | Regulation of the MET oncogene: molecular mechanisms |
Q36997971 | Taspase 1: A protease with many biological surprises |
Q34452426 | Taspase1 cleaves MLL1 to activate cyclin E for HER2/neu breast tumorigenesis |
Q35183840 | Taspase1-dependent TFIIA cleavage coordinates head morphogenesis by limiting Cdkn2a locus transcription. |
Q34555986 | The ETS family of oncogenic transcription factors in solid tumours. |
Q89967621 | The Function of the HGF/c-Met Axis in Hepatocellular Carcinoma |
Q91754947 | The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance |
Q34309954 | The c-Met Inhibitor MSC2156119J Effectively Inhibits Tumor Growth in Liver Cancer Models |
Q38923535 | c-MET receptor tyrosine kinase as a molecular target in advanced hepatocellular carcinoma |
Q91712585 | lncRNA MIAT promotes cell invasion and migration in esophageal cancer |
Search more.